Correlation Between Salesforce and Plandai Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Salesforce and Plandai Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and Plandai Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salesforce and Plandai Biotech, you can compare the effects of market volatilities on Salesforce and Plandai Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of Plandai Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and Plandai Biotech.

Diversification Opportunities for Salesforce and Plandai Biotech

-0.19
  Correlation Coefficient

Good diversification

The 3 months correlation between Salesforce and Plandai is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and Plandai Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Plandai Biotech and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with Plandai Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Plandai Biotech has no effect on the direction of Salesforce i.e., Salesforce and Plandai Biotech go up and down completely randomly.

Pair Corralation between Salesforce and Plandai Biotech

Considering the 90-day investment horizon Salesforce is expected to generate 19.12 times less return on investment than Plandai Biotech. But when comparing it to its historical volatility, Salesforce is 25.35 times less risky than Plandai Biotech. It trades about 0.36 of its potential returns per unit of risk. Plandai Biotech is currently generating about 0.27 of returns per unit of risk over similar time horizon. If you would invest  0.01  in Plandai Biotech on August 27, 2024 and sell it today you would earn a total of  0.01  from holding Plandai Biotech or generate 100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Salesforce  vs.  Plandai Biotech

 Performance 
       Timeline  
Salesforce 

Risk-Adjusted Performance

19 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Salesforce are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Salesforce displayed solid returns over the last few months and may actually be approaching a breakup point.
Plandai Biotech 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Plandai Biotech are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite quite uncertain basic indicators, Plandai Biotech disclosed solid returns over the last few months and may actually be approaching a breakup point.

Salesforce and Plandai Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Salesforce and Plandai Biotech

The main advantage of trading using opposite Salesforce and Plandai Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, Plandai Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Plandai Biotech will offset losses from the drop in Plandai Biotech's long position.
The idea behind Salesforce and Plandai Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk